Loading viewer...
brochure
Format: PDF brochure
cdda0542d9e657a586264c4ce965b5b3e11a by Inhibrx.
Let us design a presentation that delivers.
INBRX-106 Hexavalent Anti-OX40 Agonist Inhibrx Solid Tumors
investor_presentation
1 Pages
Inhibrx 2022 Investor Presentation - Clinical Pipeline Update
Entergy Corporation
Cigna
46 Pages
presentation
Inhibrx INBRX-109 Phase 1 Ewing Sarcoma Clinical Trial 2021
conference
Inhibrx INBX Investor Presentation September 2023
36 Pages
Mammoth Energy Services
Boston Consulting Group
KVAT Foods
Deutsche Bank